A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma (Q35212620)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma |
scientific article |
Statements
1 reference
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma (English)
1 reference
S O'Day
1 reference
A Pavlick
1 reference
C Loquai
1 reference
D Lawson
1 reference
R Gutzmer
1 reference
J Richards
1 reference
D Schadendorf
1 reference
J A Thompson
1 reference
R Gonzalez
1 reference
U Trefzer
1 reference
P Mohr
1 reference
D Chao
1 reference
B Zhong
1 reference
C J de Boer
1 reference
C Uhlar
1 reference
D Marshall
1 reference
M E Gore
1 reference
Z Lang
1 reference
W Hait
1 reference
P Ho
1 reference
CNTO 95 Investigators
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference